Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Vaxcyte, Inc. (PCVX)
USD56.53
+0.32 (+0.57%)
US NASDAQ Healthcare Biotechnology
Address
825 Industrial Road 94070
San Carlos, CA, US
San Carlos, CA, US
CEO
Grant E. Pickering
Website
vaxcyte.com
IPO
2020-06-12
CIK 1649094 ISIN US92243G1085
Description
Vaxcyte, Inc. is a biotechnology firm in the clinical development stage, dedicated to creating innovative protein-based vaccines. Its primary objective is to either prevent or manage bacterial infectious diseases. The company's leading vaccine candidate is VAX-24, an experimental 24-valent pneumococcal conjugate vaccine currently undergoing Phase 1/2 clinical trials, intended to address invasive pneumococcal disease and pneumonia. Beyond its flagship candidate, Vaxcyte is also advancing several other vaccine programs: VAX-XP, designed to offer protection against emergent bacterial strains and counter antimicrobial resistance; VAX-A1, a conjugate vaccine formulation aimed at Group A Streptococcus; and VAX-PG, a novel protein vaccine specifically developed to target the key pathogen responsible for periodontitis. The organization, which was initially established as SutroVax, Inc., officially rebranded as Vaxcyte, Inc. in May 2020. Founded in 2013, its corporate headquarters are situated in San Carlos, California.
News Sentiment (7d)
Based on only 1 article — low confidence
- Vaxcyte to Participate in Upcoming Investor Conferences GlobeNewsWire
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD56.53
+0.32 (+0.57%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.24
Float Shares
132.27M
Free Float %
91.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.07% | -1.78% | -11.25% | -1.67% | +17.20% | +17.10% | +71.04% | +9.20% | +189.39% | +106.62% | +106.62% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (11 ratings, all time)
Buy
Price Targets & DCF
Current price
56.53
Low
77.00
+36.2%
Consensus
83.00
+46.8%
Median
83.00
+46.8%
High
89.00
+57.4%
Ratings Trend (MoM)
91% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 9 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
89.00
+57.4%
|
| Last Year | 2 |
83.00
+46.8%
|
| All Time | 15 |
110.40
+95.3%
|
Quality scores
Altman Z-Score
11.61
Safe zone
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-48.2% Q1'26: -121.2% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-56.7% Q1'26: -100.6% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+11.6% Q1'26: +2.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.31× Q1'26: -0.09× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 6 EPS Ana. |
Dec 2027 8 Rev. Ana. 6 EPS Ana. |
Dec 2028 8 Rev. Ana. 6 EPS Ana. |
Dec 2029 7 Rev. Ana. 4 EPS Ana. |
Dec 2030 7 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 500.0K (-100.0%)
|
—
|
—
|
25.00M
25.00M – 25.00M
|
87.15M
87.15M – 87.15M
+248.6% YoY
|
177.18M
177.18M – 177.18M
+103.3% YoY
|
1.49B
1.49B – 1.49B
+740.9% YoY
|
2.50B
2.50B – 2.50B
+68.0% YoY
|
| EBITDA |
-87.81M
|
-448.08M
|
-741.77M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-89.21M
|
-463.93M
|
-766.63M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-89.22M
est: -662.75M (+86.5%)
|
-463.93M
est: -547.50M (+15.3%)
|
-766.63M
est: -755.04M (-1.5%)
|
-1.23B
-1.38B – -869.87M
-63.0% YoY
|
-1.17B
-1.31B – -666.56M
+5.0% YoY
|
-1.06B
-1.50B – -626.29M
+9.5% YoY
|
195.77M
195.77M – 195.77M
+118.5% YoY
|
963.51M
963.51M – 963.51M
+392.2% YoY
|
| SGA |
14.61M
|
92.90M
|
129.37M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-2.97
est: -5.43 (+45.3%)
|
-3.80
est: -3.91 (+2.8%)
|
-5.63
est: -5.44 (-3.5%)
|
-8.08
-10.11 – -6.39
-48.6% YoY
|
-6.62
-9.61 – -4.90
+18.1% YoY
|
-6.36
-10.99 – -4.60
+4.0% YoY
|
1.44
1.44 – 1.44
+122.6% YoY
|
7.08
7.08 – 7.08
+392.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
63
Total invested
228.53M
Insider transactions (90d)
1
Beneficial owners (>5%)
24
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Abigail P. Johnson | 5.67M | 11.18% | — | — | 5.67M | — | IN | Delaware | 2020-08-10 | ↗ |
| 2 | FMR LLC | 5.67M | 11.18% | 1.34M | — | 5.67M | — | HC | Delaware | 2020-08-10 | ↗ |
| 3 | Peter Kolchinsky | 5.49M | 10.80% | — | 5.49M | — | — | HC, IN | Delaware | 2020-07-10 | ↗ |
| 4 | RA Capital Management, L.P. | 5.49M | 10.80% | — | 5.49M | — | — | IA, PN | Delaware | 2020-07-10 | ↗ |
| 5 | Rajeev Shah | 5.49M | 10.80% | — | 5.49M | — | — | HC, IN | Delaware | 2020-07-10 | ↗ |
| 6 | (1) BlackRock, Inc. | 5.11M | 6.50% | 5.03M | — | 5.11M | — | HC | Delaware | 2023-02-03 | ↗ |
| 7 | Bonderman | 4.73M | 9.30% | — | 4.73M | — | — | IN | Delaware | 2021-02-12 | ↗ |
| 8 | G. Coulter | 4.73M | 9.30% | — | 4.73M | — | — | IN | Delaware | 2021-02-12 | ↗ |
| 9 | Group Holdings (SBS) Advisors, Inc. | 4.73M | 9.30% | — | 4.73M | — | — | CO | Delaware | 2021-02-12 | ↗ |
| 10 | EIN #00-0000000 | 4.25M | 8.00% | — | 4.25M | — | 4.25M | IA, HC | Jersey, Channel Islands | 2022-02-10 | ↗ |
| 11 | Abingworth Bioventures VI, LP | 4.18M | 7.90% | — | 4.18M | — | — | IA | England | 2022-02-14 | ↗ |
| 12 | Abingworth LLP | 4.18M | 7.90% | — | 4.18M | — | — | IA | England | 2022-02-14 | ↗ |
| 13 | VI, LP | 4.17M | 8.20% | — | 4.17M | — | — | IA | England | 2021-02-16 | ↗ |
| 14 | David Bonderman | 4.15M | 7.90% | — | 4.15M | — | — | IN | Delaware | 2022-01-18 | ↗ |
| 15 | James G. Coulter | 4.15M | 7.90% | — | 4.15M | — | — | IN | Delaware | 2022-01-18 | ↗ |
| 16 | Jon Winkelried | 4.15M | 7.90% | — | 4.15M | — | — | IN | Delaware | 2022-01-18 | ↗ |
| 17 | TPG GP A, LLC | 4.15M | 7.90% | — | 4.15M | — | — | OO | Delaware | 2022-01-18 | ↗ |
| 18 | The Vanguard Group - 23-1945930 | 3.13M | 5.94% | — | — | — | — | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 19 | Juliet Tammenoms Bakker | 3.11M | 6.10% | 2.4K | 3.11M | 2.4K | 3.11M | IN | — | 2021-02-12 | ↗ |
| 20 | Patrick G. Enright | 3.11M | 6.10% | 2.4K | 3.11M | 2.4K | 3.11M | IN | — | 2021-02-12 | ↗ |
| 21 | Longitude Capital Partners II, LLC | 3.11M | 6.10% | — | 3.11M | — | 3.11M | OO | — | 2021-02-12 | ↗ |
| 22 | Longitude Venture Partners II, L.P. | 3.11M | 6.10% | — | 3.11M | — | 3.11M | PN | — | 2021-02-12 | ↗ |
| 23 | Roche Finance Ltd | 2.33M | 4.40% | — | — | — | — | CO | Switzerland | 2022-02-14 | ↗ |
| 24 | Roche Holding Ltd | 2.33M | 4.40% | — | — | — | — | CO | Switzerland | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
63
-239 vs prev Q
New positions
13
Closed positions
244
Increased
31
Reduced
16
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 737.5K +737.5K (+100.0%) | 34.03B +34.0B (+100.0%) | 0.54% +0.542 pp | 8.41% +8.407 pp | USD46.14 +0.0% | 1 qtrs NEW |
| 2 | FMR LLC | 13.83M +1.3M (+10.6%) | 638.32M +187.7M (+41.7%) | 10.16% +0.962 pp | 0.03% +0.009 pp | USD41.84 +10.3% | 23 qtrs — |
| 3 | JANUS HENDERSON GROUP PLC | 13.39M +283.0K (+2.2%) | 617.73M +145.7M (+30.9%) | 9.83% +0.196 pp | 0.28% +0.061 pp | USD50.22 -8.1% | 23 qtrs — |
| 4 | VANGUARD GROUP INC | 12.19M -126.5K (-1.0%) | 562.63M +118.8M (+26.8%) | 8.95% -0.104 pp | 0.01% +0.002 pp | USD54.10 -14.7% | 23 qtrs — |
| 5 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11.30M +3.0M (+35.9%) | 521.21M +221.7M (+74.0%) | 8.29% +2.182 pp | 0.33% +0.146 pp | USD43.96 +5.0% | 13 qtrs — |
| 6 | RA CAPITAL MANAGEMENT, L.P. | 10.72M -1.2M (-10.4%) | 494.83M +63.8M (+14.8%) | 7.87% -0.922 pp | 5.07% -0.241 pp | USD40.28 +14.5% | 23 qtrs — |
| 7 | BLACKROCK, INC. | 10.25M +290.4K (+2.9%) | 472.77M +114.2M (+31.8%) | 7.52% +0.205 pp | 0.01% +0.002 pp | USD110.63 -58.3% | 6 qtrs — |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 5.97M +933.5K (+18.5%) | 275.29M +94.0M (+51.9%) | 4.38% +0.681 pp | 0.05% +0.017 pp | USD42.05 +9.7% | 23 qtrs — |
| 9 | STATE STREET CORP | 4.98M +194.1K (+4.1%) | 229.78M +57.4M (+33.3%) | 3.66% +0.138 pp | 0.01% +0.002 pp | USD46.71 -1.2% | 22 qtrs — |
| 10 | PARADIGM BIOCAPITAL ADVISORS LP | 4.07M +283.3K (+7.5%) | 187.70M +51.4M (+37.7%) | 2.99% +0.205 pp | 4.79% +0.914 pp | USD49.10 -6.0% | 8 qtrs — |
| 11 | DEEP TRACK CAPITAL, LP | 4.00M +1.0M (+33.3%) | 184.56M +76.5M (+70.8%) | 2.94% +0.732 pp | 3.29% +0.275 pp | USD37.65 +22.5% | 4 qtrs — |
| 12 | D. E. SHAW & CO., INC. | 3.63M -659.7K (-15.4%) | 167.54M +13.0M (+8.4%) | 2.67% -0.488 pp | 0.09% +0.005 pp | USD42.17 +9.4% | 13 qtrs — |
| 13 | WESTFIELD CAPITAL MANAGEMENT CO LP | 3.54M -193.0K (-5.2%) | 163.32M +28.9M (+21.5%) | 2.60% -0.145 pp | 0.68% +0.116 pp | USD52.85 -12.7% | 10 qtrs — |
| 14 | KYNAM CAPITAL MANAGEMENT, LP | 2.92M -149.3K (-4.9%) | 134.84M +24.2M (+21.9%) | 2.15% -0.112 pp | 8.61% +0.376 pp | USD60.98 -24.3% | 17 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 2.87M -17.7K (-0.6%) | 132.27M +28.4M (+27.3%) | 2.10% -0.016 pp | 0.01% +0.002 pp | USD52.93 -12.8% | 23 qtrs — |
| 16 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.73M +1.4M (+418.0%) | 79.59M +67.6M (+563.6%) | 1.27% +1.022 pp | 0.12% +0.102 pp | USD44.19 +4.4% | 2 qtrs — |
| 17 | CALIGAN PARTNERS LP | 1.70M +1.7M (+100.0%) | 78.66M +78.7M (+100.0%) | 1.25% +1.252 pp | 6.48% +6.475 pp | USD46.14 +0.0% | 1 qtrs NEW |
| 18 | POLAR CAPITAL HOLDINGS PLC | 1.67M +1.3M (+302.6%) | 77.18M +62.2M (+415.7%) | 1.23% +0.923 pp | 0.30% +0.226 pp | USD61.15 -24.5% | 6 qtrs — |
| 19 | PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.37M +— (+0.0%) | 63.32M +13.9M (+28.1%) | 1.01% -0.001 pp | 24.48% -4.096 pp | USD33.63 +37.2% | 21 qtrs — |
| 20 | MAVERICK CAPITAL LTD | 1.35M +64.7K (+5.0%) | 62.48M +16.0M (+34.5%) | 0.99% +0.046 pp | 0.67% +0.050 pp | USD77.98 -40.8% | 8 qtrs — |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.29M +423.0 (+0.0%) | 59.70M +13.1M (+28.1%) | 0.95% -0.001 pp | 0.01% +0.002 pp | USD66.63 -30.8% | 22 qtrs — |
| 22 | NORGES BANK | 1.23M +1.2M (+100.0%) | 56.70M +56.7M (+100.0%) | 0.90% +0.902 pp | 0.01% +0.006 pp | USD46.14 +0.0% | 1 qtrs NEW |
| 23 | EVERSEPT PARTNERS, LP | 1.20M -224.3K (-15.8%) | 55.26M +4.0M (+7.9%) | 0.88% -0.166 pp | 2.78% -0.745 pp | USD38.83 +18.8% | 13 qtrs — |
| 24 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.18M -513.1K (-30.4%) | 54.23M -6.6M (-10.8%) | 0.86% -0.378 pp | 0.01% -0.001 pp | USD71.17 -35.2% | 19 qtrs — |
| 25 | UBS GROUP AG | 1.09M +246.0K (+29.0%) | 50.46M +19.9M (+65.3%) | 0.80% +0.180 pp | 0.01% +0.003 pp | USD55.99 -17.6% | 22 qtrs — |
| 26 | JPMORGAN CHASE & CO | 1.09M -479.5K (-30.6%) | 50.09M -6.3M (-11.2%) | 0.80% -0.353 pp | 0.00% 0.000 pp | USD59.80 -22.8% | 22 qtrs — |
| 27 | GOLDMAN SACHS GROUP INC | 1.08M +102.7K (+10.5%) | 49.74M +14.6M (+41.6%) | 0.79% +0.075 pp | 0.01% +0.002 pp | USD70.92 -34.9% | 23 qtrs — |
| 28 | NORTHERN TRUST CORP | 1.03M -39.2K (-3.6%) | 47.72M +9.1M (+23.4%) | 0.76% -0.030 pp | 0.01% +0.001 pp | USD53.19 -13.3% | 22 qtrs — |
| 29 | ABRDN PLC | 979.8K +257.0K (+35.6%) | 45.21M +19.2M (+73.6%) | 0.72% +0.188 pp | 0.07% +0.029 pp | USD47.08 -2.0% | 9 qtrs — |
| 30 | EVENTIDE ASSET MANAGEMENT, LLC | 917.1K +537.8K (+141.8%) | 42.31M +28.7M (+209.8%) | 0.67% +0.395 pp | 0.66% +0.436 pp | USD45.56 +1.3% | 10 qtrs — |
| 31 | NOVO HOLDINGS A/S | 916.2K +— (+0.0%) | 42.27M +9.3M (+28.1%) | 0.67% -0.001 pp | 3.28% +1.156 pp | USD32.35 +42.6% | 15 qtrs — |
| 32 | PICTET ASSET MANAGEMENT HOLDING SA | 881.4K -148.2K (-14.4%) | 40.67M +3.6M (+9.7%) | 0.65% -0.110 pp | 0.04% +0.004 pp | USD68.22 -32.4% | 10 qtrs — |
| 33 | CAPITAL RESEARCH GLOBAL INVESTORS | 843.0K +— (+0.0%) | 38.90M +8.5M (+28.1%) | 0.62% -0.001 pp | 0.01% +0.002 pp | USD63.68 -27.5% | 14 qtrs — |
| 34 | MORGAN STANLEY | 835.4K +50.9K (+6.5%) | 38.54M +10.3M (+36.4%) | 0.61% +0.037 pp | 0.00% +0.001 pp | USD63.24 -27.0% | 23 qtrs — |
| 35 | SATURN V CAPITAL MANAGEMENT LLC | 798.9K +10.5K (+1.3%) | 36.86M +8.5M (+29.8%) | 0.59% +0.007 pp | 6.77% +0.537 pp | USD43.07 +7.1% | 8 qtrs — |
| 36 | BANK OF AMERICA CORP /DE/ | 701.6K +66.6K (+10.5%) | 32.37M +9.5M (+41.5%) | 0.52% +0.048 pp | 0.00% +0.001 pp | USD49.84 -7.4% | 23 qtrs — |
| 37 | JENNISON ASSOCIATES LLC | 677.6K -493.3K (-42.1%) | 31.26M -10.9M (-25.9%) | 0.50% -0.363 pp | 0.02% -0.006 pp | USD47.61 -3.1% | 13 qtrs — |
| 38 | LOGOS GLOBAL MANAGEMENT LP | 650.0K +25.0K (+4.0%) | 29.99M +7.5M (+33.2%) | 0.48% +0.018 pp | 1.81% -0.206 pp | USD36.41 +26.7% | 2 qtrs — |
| 39 | SOLEUS CAPITAL MANAGEMENT, L.P. | 609.0K +609.0K (+100.0%) | 28.10M +28.1M (+100.0%) | 0.45% +0.447 pp | 1.04% +1.037 pp | USD46.14 +0.0% | 1 qtrs NEW |
| 40 | BROWN ADVISORY INC | 566.9K -110.1K (-16.3%) | 26.16M +1.8M (+7.3%) | 0.42% -0.081 pp | 0.04% +0.005 pp | USD74.72 -38.2% | 7 qtrs — |
| 41 | VICTORY CAPITAL MANAGEMENT INC | 549.5K +234.6K (+74.5%) | 25.35M +14.0M (+123.5%) | 0.40% +0.172 pp | 0.01% +0.008 pp | USD42.63 +8.2% | 16 qtrs — |
| 42 | ASSENAGON ASSET MANAGEMENT S.A. | 544.7K +324.8K (+147.7%) | 25.13M +17.2M (+217.2%) | 0.40% +0.238 pp | 0.03% +0.024 pp | USD42.21 +9.3% | 4 qtrs — |
| 43 | ENSIGN PEAK ADVISORS, INC | 527.7K -1.2K (-0.2%) | 24.35M +5.3M (+27.8%) | 0.39% -0.001 pp | 0.04% +0.012 pp | USD56.26 -18.0% | 17 qtrs — |
| 44 | FEDERATED HERMES, INC. | 523.5K +505.3K (+2,783.3%) | 24.15M +23.5M (+3,593.4%) | 0.38% +0.371 pp | 0.04% +0.039 pp | USD45.79 +0.8% | 13 qtrs — |
| 45 | BOOTHBAY FUND MANAGEMENT, LLC | 497.7K +369.0K (+286.7%) | 22.97M +18.3M (+395.3%) | 0.37% +0.271 pp | 0.34% +0.275 pp | USD43.48 +6.1% | 4 qtrs — |
| 46 | ECOR1 CAPITAL, LLC | 450.0K +450.0K (+100.0%) | 20.76M +20.8M (+100.0%) | 0.33% +0.330 pp | 0.94% +0.942 pp | USD46.14 +0.0% | 1 qtrs NEW |
| 47 | BANK OF NEW YORK MELLON CORP | 449.4K +9.8K (+2.2%) | 20.73M +4.9M (+30.9%) | 0.33% +0.007 pp | 0.00% +0.001 pp | USD45.97 +0.4% | 22 qtrs — |
| 48 | MILLENNIUM MANAGEMENT LLC | 424.3K -524.7K (-55.3%) | 19.58M -14.6M (-42.7%) | 0.31% -0.386 pp | 0.01% -0.006 pp | USD40.55 +13.8% | 23 qtrs — |
| 49 | UBS ASSET MANAGEMENT AMERICAS INC | 389.0K -9.1K (-2.3%) | 17.95M +3.6M (+25.2%) | 0.29% -0.007 pp | 0.00% +0.001 pp | USD72.83 -36.6% | 15 qtrs — |
| 50 | IKARIAN CAPITAL, LLC | 378.7K +67.0K (+21.5%) | 17.47M +6.2M (+55.6%) | 0.28% +0.049 pp | 1.36% +0.231 pp | USD37.76 +22.2% | 4 qtrs — |
| 51 | TD ASSET MANAGEMENT INC | 363.7K -34.7K (-8.7%) | 16.78M +2.4M (+16.9%) | 0.27% -0.026 pp | 0.01% +0.002 pp | USD52.12 -11.5% | 13 qtrs — |
| 52 | AMERICAN CENTURY COMPANIES INC | 357.3K +13.3K (+3.9%) | 16.49M +4.1M (+33.0%) | 0.26% +0.009 pp | 0.01% +0.002 pp | USD58.84 -21.6% | 13 qtrs — |
| 53 | DEUTSCHE BANK AG\ | 342.9K -54.9K (-13.8%) | 15.82M +1.5M (+10.4%) | 0.25% -0.041 pp | 0.01% +0.000 pp | USD82.25 -43.9% | 22 qtrs — |
| 54 | FRANKLIN RESOURCES INC | 336.1K +37.0 (+0.0%) | 15.51M +3.4M (+28.1%) | 0.25% 0.000 pp | 0.00% +0.001 pp | USD62.95 -26.7% | 13 qtrs — |
| 55 | CITADEL ADVISORS LLC | 326.6K +120.8K (+58.7%) | 15.07M +7.7M (+103.3%) | 0.24% +0.089 pp | 0.00% +0.001 pp | USD40.37 +14.3% | 23 qtrs — |
| 56 | ADAR1 CAPITAL MANAGEMENT, LLC | 315.6K +102.6K (+48.1%) | 14.56M +6.9M (+89.8%) | 0.23% +0.075 pp | 1.07% +0.349 pp | USD38.43 +20.1% | 9 qtrs — |
| 57 | NUVEEN, LLC | 307.2K -177.4K (-36.6%) | 14.17M -3.3M (-18.8%) | 0.23% -0.131 pp | 0.00% -0.001 pp | USD37.76 +22.2% | 4 qtrs — |
| 58 | AMERIPRISE FINANCIAL INC | 305.2K -69.7K (-18.6%) | 14.08M +577.7K (+4.3%) | 0.22% -0.052 pp | 0.00% +0.000 pp | USD75.79 -39.1% | 10 qtrs — |
| 59 | ARTISAN PARTNERS LIMITED PARTNERSHIP | 304.0K +304.0K (+100.0%) | 14.03M +14.0M (+100.0%) | 0.22% +0.223 pp | 0.02% +0.021 pp | USD46.14 +0.0% | 1 qtrs NEW |
| 60 | BARCLAYS PLC | 296.2K +86.4K (+41.2%) | 13.67M -10.3M (-43.0%) | 0.22% +0.063 pp | 0.00% -0.003 pp | USD51.67 -10.7% | 16 qtrs — |
| 61 | JANE STREET GROUP, LLC | 279.6K -64.1K (-18.6%) | 12.90M +521.0K (+4.2%) | 0.21% -0.047 pp | 0.00% +0.000 pp | USD53.01 -13.0% | 13 qtrs — |
| 62 | TANG CAPITAL MANAGEMENT LLC | 275.0K -25.0K (-8.3%) | 12.69M +1.9M (+17.4%) | 0.20% -0.019 pp | 0.63% +0.211 pp | USD47.95 -3.8% | 13 qtrs — |
| 63 | WOODLINE PARTNERS LP | 274.7K +27.8K (+11.2%) | 12.68M +3.8M (+42.5%) | 0.20% +0.020 pp | 0.05% +0.007 pp | USD66.16 -30.3% | 17 qtrs — |
| 64 | UNIVERSITY OF WISCONSIN FOUNDATION | 247.0K +247.0K (+100.0%) | 11.40M +11.4M (+100.0%) | 0.18% +0.181 pp | 9.58% +9.583 pp | USD46.14 +0.0% | 1 qtrs NEW |
| 65 | ALYESKA INVESTMENT GROUP, L.P. | 244.8K +— (+0.0%) | 11.29M +2.5M (+28.1%) | 0.18% 0.000 pp | 0.03% +0.005 pp | USD87.50 -47.3% | 6 qtrs — |
| 66 | CITIGROUP INC | 241.9K -71.2K (-22.7%) | 11.16M -116.7K (-1.0%) | 0.18% -0.053 pp | 0.00% 0.000 pp | USD59.23 -22.1% | 22 qtrs — |
| 67 | SWISS NATIONAL BANK | 230.4K +5.3K (+2.4%) | 10.63M +2.5M (+31.1%) | 0.17% +0.004 pp | 0.01% +0.002 pp | USD48.48 -4.8% | 21 qtrs — |
| 68 | QUBE RESEARCH & TECHNOLOGIES LTD | 207.1K -346.8K (-62.6%) | 9.56M -10.4M (-52.1%) | 0.15% -0.255 pp | 0.01% -0.011 pp | USD32.51 +41.9% | 5 qtrs — |
| 69 | C WORLDWIDE GROUP HOLDING A/S | 195.0K +— (+0.0%) | 9.00M +2.0M (+28.1%) | 0.14% 0.000 pp | 0.16% +0.049 pp | USD35.07 +31.6% | 4 qtrs — |
| 70 | SEGALL BRYANT & HAMILL, LLC | 193.4K +8.6K (+4.7%) | 8.92M +2.3M (+34.1%) | 0.14% +0.006 pp | 0.12% +0.032 pp | USD56.95 -19.0% | 9 qtrs — |
| 71 | DIMENSIONAL FUND ADVISORS LP | 191.8K +163.4K (+576.1%) | 8.85M +7.8M (+766.0%) | 0.14% +0.120 pp | 0.00% +0.002 pp | USD52.51 -12.1% | 15 qtrs — |
| 72 | RAYMOND JAMES FINANCIAL INC | 185.9K -3.4K (-1.8%) | 8.45M +1.6M (+24.0%) | 0.14% -0.003 pp | 0.00% +0.000 pp | USD76.61 -39.8% | 5 qtrs — |
| 73 | POINT72 ASSET MANAGEMENT, L.P. | 161.6K -535.2K (-76.8%) | 7.46M -17.6M (-70.3%) | 0.12% -0.394 pp | 0.01% -0.034 pp | USD36.02 +28.1% | 6 qtrs — |
| 74 | RHUMBLINE ADVISERS | 150.9K -32.3K (-17.6%) | 6.96M +364.1K (+5.5%) | 0.11% -0.024 pp | 0.01% +0.000 pp | USD46.57 -0.9% | 22 qtrs — |
| 75 | SILVERARC CAPITAL MANAGEMENT, LLC | 148.8K -165.6K (-52.7%) | 6.87M -4.5M (-39.4%) | 0.11% -0.122 pp | 0.95% -0.573 pp | USD32.81 +40.6% | 7 qtrs — |
| 76 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 144.6K -11.0 (0.0%) | 6.67M +1.5M (+28.1%) | 0.11% 0.000 pp | 0.00% +0.001 pp | USD67.07 -31.2% | 10 qtrs — |
| 77 | NAN FUNG TRINITY (HK) LTD | 142.9K +38.7K (+37.1%) | 6.59M +2.8M (+75.6%) | 0.10% +0.028 pp | 0.52% +0.148 pp | USD36.20 +27.5% | 3 qtrs — |
| 78 | INVESCO LTD. | 141.2K -37.9K (-21.1%) | 6.52M +65.4K (+1.0%) | 0.10% -0.028 pp | 0.00% +0.000 pp | USD67.28 -31.4% | 19 qtrs — |
| 79 | WELLS FARGO & COMPANY/MN | 134.1K +8.0K (+6.4%) | 6.19M +1.6M (+36.3%) | 0.10% +0.006 pp | 0.00% +0.000 pp | USD50.18 -8.1% | 22 qtrs — |
| 80 | ALLIANCEBERNSTEIN L.P. | 133.9K -1.3K (-1.0%) | 6.18M +1.3M (+26.8%) | 0.10% -0.001 pp | 0.00% +0.000 pp | USD51.99 -11.3% | 22 qtrs — |
| 81 | RAFFERTY ASSET MANAGEMENT, LLC | 133.8K -15.7K (-10.5%) | 6.17M +790.0K (+14.7%) | 0.10% -0.012 pp | 0.02% +0.004 pp | USD55.83 -17.4% | 21 qtrs — |
| 82 | READYSTATE ASSET MANAGEMENT LP | 131.6K +131.6K (+100.0%) | 6.07M +6.1M (+100.0%) | 0.10% +0.097 pp | 0.25% +0.246 pp | USD46.14 +0.0% | 3 qtrs — |
| 83 | CORMORANT ASSET MANAGEMENT, LP | 125.0K -50.0K (-28.6%) | 5.77M -536.0K (-8.5%) | 0.09% -0.037 pp | 0.27% -0.168 pp | USD59.93 -23.0% | 13 qtrs — |
| 84 | LEGAL & GENERAL GROUP PLC | 120.3K -10.1K (-7.7%) | 5.55M +853.6K (+18.2%) | 0.09% -0.008 pp | 0.00% +0.000 pp | USD52.22 -11.6% | 22 qtrs — |
| 85 | NEW YORK STATE COMMON RETIREMENT FUND | 116.8K -5.0K (-4.1%) | 5.39M +1.0M (+22.9%) | 0.09% -0.004 pp | 0.01% +0.002 pp | USD40.56 +13.8% | 22 qtrs — |
| 86 | HIGHVISTA STRATEGIES LLC | 114.0K +27.2K (+31.4%) | 5.26M +2.1M (+68.3%) | 0.08% +0.020 pp | 1.36% +0.589 pp | USD49.96 -7.6% | 15 qtrs — |
| 87 | HRT FINANCIAL LP | 114.0K -84.0 (-0.1%) | 5.26M +1.2M (+28.0%) | 0.08% 0.000 pp | 0.02% +0.002 pp | USD36.02 +28.1% | 2 qtrs — |
| 88 | TWO SIGMA INVESTMENTS, LP | 111.3K +3.7K (+3.5%) | 5.14M +1.3M (+32.5%) | 0.08% +0.003 pp | 0.01% +0.002 pp | USD33.60 +37.3% | 3 qtrs — |
| 89 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 110.9K +1.4K (+1.3%) | 5.12M +1.2M (+29.8%) | 0.08% +0.001 pp | 0.01% +0.001 pp | USD47.08 -2.0% | 22 qtrs — |
| 90 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 108.4K -28.4K (-20.8%) | 4.97M +36.4K (+0.7%) | 0.08% -0.021 pp | 0.00% +0.000 pp | USD54.74 -15.7% | 22 qtrs — |
| 91 | CREATIVE PLANNING | 102.7K +22.4K (+27.8%) | 4.74M +1.8M (+63.8%) | 0.08% +0.016 pp | 0.00% +0.001 pp | USD53.20 -13.3% | 13 qtrs — |
| 92 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 93.3K +6.1K (+7.0%) | 4.30M +1.2M (+37.1%) | 0.07% +0.004 pp | 0.00% +0.000 pp | USD49.59 -7.0% | 14 qtrs — |
| 93 | JUMP FINANCIAL, LLC | 89.8K -101.9K (-53.1%) | 4.14M -2.8M (-40.0%) | 0.07% -0.075 pp | 0.05% -0.032 pp | USD33.81 +36.5% | 8 qtrs — |
| 94 | TWINBEECH CAPITAL LP | 78.2K -149.8K (-65.7%) | 3.61M -4.6M (-56.1%) | 0.06% -0.110 pp | 0.26% -0.069 pp | USD61.27 -24.7% | 5 qtrs — |
| 95 | BANQUE PICTET & CIE SA | 71.8K -3.0K (-4.1%) | 3.31M +616.9K (+22.9%) | 0.05% -0.002 pp | 0.02% +0.004 pp | USD59.21 -22.1% | 8 qtrs — |
| 96 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 70.1K +36.0K (+105.3%) | 3.24M +2.0M (+163.0%) | 0.05% +0.026 pp | 0.01% +0.003 pp | USD57.50 -19.8% | 5 qtrs — |
| 97 | MAN GROUP PLC | 68.9K -176.0K (-71.9%) | 3.18M -5.6M (-64.0%) | 0.05% -0.129 pp | 0.01% -0.010 pp | USD41.94 +10.0% | 6 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 131 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Harbor Health Care ETF (MEDI) MEDI | 2.11% | 919.8K | 0.80% |
| 2 | Fidelity Disruptive Medicine ETF FMED | 1.90% | 882.8K | 0.50% |
| 3 | Global X - S&P Biotech ETF CURE.AX | 1.18% | 424.8K | 0.45% |
| 4 | State Street SPDR S&P Biotech ETF XBI | 1.18% | 127.95M | 0.35% |
| 5 | Virtus Biotech Clinical Trials ETF BBC | 0.75% | 434.5K | 0.65% |
| 6 | iShares Biotechnology ETF IBB | 0.63% | 59.33M | 0.44% |
| 7 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.58% | 433.5K | 0.19% |
| 8 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.58% | 2.68M | 0.40% |
| 9 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.58% | 6.32M | 0.35% |
| 10 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.58% | 423.3K | 0.35% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.20
Bearish
Ratio by volume
0.29
Bearish
Buys
1
Sells
5
Shares acquired
3.0K
Shares disposed
10.5K
Cash buys
—
Cash sales
4.00
Net activity
-7,500
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Wassil Jim | Officer | S-Sale | D | Common Stock | 2,250 | 56.83 | 127.9K | 160,744 | D | ↗ |
| 2026-04-07 | Cowan Elvia | Officer | M-Exempt | D | Stock Option (right to buy) | 3,000 | 25.92 | 77.8K | 93,068 | D | ↗ |
| 2026-04-01 | Wassil Jim | Officer | S-Sale | D | Common Stock | 1,412 | 58.14 | 82.1K | 165,406 | D | ↗ |
| 2026-03-17 | Cowan Elvia | Officer | S-Sale | D | Common Stock | 1,487 | 55.39 | 82.4K | 29,380 | D | ↗ |
| 2026-03-11 | Cowan Elvia | Officer | M-Exempt | D | Stock Option (right to buy) | 2,500 | 25.92 | 64.8K | 96,068 | D | ↗ |
| 2026-03-10 | Wassil Jim | Officer | S-Sale | D | Common Stock | 4,968 | 59.16 | 293.9K | 166,818 | D | ↗ |
| 2026-03-09 | Wassil Jim | Officer | F-InKind | D | Common Stock | 975 | 59.32 | 57.8K | 174,213 | D | ↗ |
| 2026-03-09 | PICKERING GRANT | Director / Officer | F-InKind | D | Common Stock | 3,685 | 59.32 | 218.6K | 496,939 | D | ↗ |
| 2026-03-09 | GUGGENHIME ANDREW | Officer | F-InKind | D | Common Stock | 1,021 | 59.32 | 60.6K | 104,395 | D | ↗ |
| 2026-03-09 | Dhaliwal Harpreet S. | Officer | F-InKind | D | Common Stock | 604 | 59.32 | 35.8K | 75,976 | D | ↗ |
| 2026-03-09 | Cowan Elvia | Officer | F-InKind | D | Common Stock | 495 | 59.32 | 29.4K | 30,867 | D | ↗ |
| 2026-03-02 | Wassil Jim | Officer | F-InKind | D | Common Stock | 1,009 | 61.98 | 62.5K | 175,188 | D | ↗ |
| 2026-03-02 | PICKERING GRANT | Director / Officer | F-InKind | D | Common Stock | 2,531 | 61.98 | 156.9K | 500,624 | D | ↗ |
| 2026-03-02 | GUGGENHIME ANDREW | Officer | F-InKind | D | Common Stock | 1,009 | 61.98 | 62.5K | 105,416 | D | ↗ |
| 2026-03-02 | Dhaliwal Harpreet S. | Officer | F-InKind | D | Common Stock | 465 | 61.98 | 28.8K | 76,580 | D | ↗ |
| 2026-03-02 | Cowan Elvia | Officer | F-InKind | D | Common Stock | 326 | 61.98 | 20.2K | 31,362 | D | ↗ |
| 2026-02-28 | Wassil Jim | Officer | F-InKind | D | Common Stock | 898 | 61.98 | 55.7K | 176,197 | D | ↗ |
| 2026-02-28 | PICKERING GRANT | Director / Officer | F-InKind | D | Common Stock | 2,863 | 61.98 | 177.4K | 503,155 | D | ↗ |
| 2026-02-28 | GUGGENHIME ANDREW | Officer | F-InKind | D | Common Stock | 898 | 61.98 | 55.7K | 106,425 | D | ↗ |
| 2026-02-28 | Dhaliwal Harpreet S. | Officer | F-InKind | D | Common Stock | 292 | 61.98 | 18.1K | 77,045 | D | ↗ |
| 2026-02-28 | Cowan Elvia | Officer | F-InKind | D | Common Stock | 243 | 61.98 | 15.1K | 31,688 | D | ↗ |
| 2026-02-27 | Wassil Jim | Officer | F-InKind | D | Common Stock | 1,900 | 61.74 | 117.3K | 177,095 | D | ↗ |
| 2026-02-26 | Wassil Jim | Officer | A-Award | A | Stock Option (right to buy) | 53,566 | 60.00 | 3.21M | 53,566 | D | ↗ |
| 2026-02-26 | PICKERING GRANT | Director / Officer | A-Award | A | Stock Option (right to buy) | 175,698 | 60.00 | 10.54M | 175,698 | D | ↗ |
| 2026-02-26 | GUGGENHIME ANDREW | Officer | A-Award | A | Stock Option (right to buy) | 74,993 | 60.00 | 4.50M | 74,993 | D | ↗ |
| 2026-02-26 | Dhaliwal Harpreet S. | Officer | A-Award | A | Stock Option (right to buy) | 46,424 | 60.00 | 2.79M | 46,424 | D | ↗ |
| 2026-02-26 | Cowan Elvia | Officer | A-Award | A | Common Stock | 10,681 | 0.00 | — | 24,215 | D | ↗ |
| 2026-01-15 | BRANDICOURT OLIVIER | Director | A-Award | A | Stock Option (right to buy) | 6,750 | 48.04 | 324.3K | 6,750 | D | ↗ |
| 2026-01-14 | PICKERING GRANT | Director / Officer | G-Gift | D | Common Stock | 100,000 | 0.00 | — | 400,908 | D | ↗ |
| 2026-01-14 | GUGGENHIME ANDREW | Officer | G-Gift | D | Common Stock | 61,850 | 0.00 | — | 62,459 | D | ↗ |
| 2025-12-31 | Dhaliwal Harpreet S. | Officer | S-Sale | D | Common Stock | 9,743 | 46.69 | 454.9K | 23,928 | D | ↗ |
| 2025-12-23 | Cowan Elvia | Officer | S-Sale | D | Common Stock | 6,716 | 47.94 | 321.9K | 14,534 | D | ↗ |
| 2025-09-08 | Wassil Jim | Officer | F-InKind | D | Common Stock | 2,759 | 32.41 | 89.4K | 141,848 | D | ↗ |
| 2025-09-08 | PICKERING GRANT | Director / Officer | F-InKind | D | Common Stock | 7,356 | 32.41 | 238.4K | 500,908 | D | ↗ |
| 2025-09-08 | GUGGENHIME ANDREW | Officer | F-InKind | D | Common Stock | 2,890 | 32.41 | 93.7K | 124,309 | D | ↗ |
| 2025-09-08 | Dhaliwal Harpreet S. | Officer | F-InKind | D | Common Stock | 1,204 | 32.41 | 39.0K | 33,670 | D | ↗ |
| 2025-09-08 | Cowan Elvia | Officer | F-InKind | D | Common Stock | 482 | 32.41 | 15.6K | 26,156 | D | ↗ |
| 2025-09-07 | Cowan Elvia | Officer | A-Award | A | Common Stock | 2,810 | 0.00 | — | 27,205 | D | ↗ |
| 2025-09-02 | Wassil Jim | Officer | F-InKind | D | Common Stock | 1,429 | 31.56 | 45.1K | 146,270 | D | ↗ |
| 2025-09-02 | PICKERING GRANT | Director / Officer | F-InKind | D | Common Stock | 3,420 | 31.56 | 107.9K | 508,264 | D | ↗ |
| 2025-09-02 | GUGGENHIME ANDREW | Officer | F-InKind | D | Common Stock | 1,429 | 31.56 | 45.1K | 127,199 | D | ↗ |
| 2025-09-02 | Dhaliwal Harpreet S. | Officer | F-InKind | D | Common Stock | 464 | 31.56 | 14.6K | 34,874 | D | ↗ |
| 2025-09-02 | Cowan Elvia | Officer | F-InKind | D | Common Stock | 325 | 31.56 | 10.3K | 26,638 | D | ↗ |
| 2025-08-29 | Cowan Elvia | Officer | A-Award | A | Stock Option (right to buy) | 9,743 | 30.79 | 300.0K | 9,743 | D | ↗ |
| 2025-06-12 | Paya Carlos V | Director | A-Award | A | Common Stock | 3,041 | 0.00 | — | 4,591 | D | ↗ |
| 2025-06-12 | Lukatch Heath | Director | A-Award | A | Stock Option (right to buy) | 15,372 | 34.46 | 529.7K | 15,372 | D | ↗ |
| 2025-06-12 | Loxam Teri | Director | A-Award | A | Common Stock | 3,041 | 0.00 | — | 10,216 | D | ↗ |
| 2025-06-12 | Lee Jacks | Director | A-Award | A | Common Stock | 3,041 | 0.00 | — | 4,591 | D | ↗ |
| 2025-06-12 | Gilbert Halley E | Director | A-Award | A | Stock Option (right to buy) | 15,372 | 34.46 | 529.7K | 15,372 | D | ↗ |
| 2025-06-12 | Furey John | Director | A-Award | A | Stock Option (right to buy) | 15,372 | 34.46 | 529.7K | 15,372 | D | ↗ |
| 2025-06-12 | Drapeau Anne S | Director | A-Award | A | Common Stock | 3,041 | 0.00 | — | 10,216 | D | ↗ |
| 2025-06-12 | BRANDICOURT OLIVIER | Director | A-Award | A | Common Stock | 1,148 | 0.00 | — | 1,148 | D | ↗ |
| 2025-05-01 | BRANDICOURT OLIVIER | Director | A-Award | A | Stock Option (right to buy) | 40,113 | 35.24 | 1.41M | 40,113 | D | ↗ |
| 2025-04-17 | Dhaliwal Harpreet S. | Officer | — | — | Stock Option (right to buy) | 45,000 | 24.79 | 1.12M | 0 | D | ↗ |
| 2025-04-08 | Lukatch Heath | Director | M-Exempt | A | Common Stock | 1,000 | 21.49 | 21.5K | 14,175 | D | ↗ |
| 2025-04-07 | GUGGENHIME ANDREW | Officer | M-Exempt | A | Common Stock | 4,777 | 20.93 | 100.0K | 131,950 | D | ↗ |
| 2025-04-04 | PICKERING GRANT | Director / Officer | M-Exempt | A | Common Stock | 15,781 | 5.35 | 84.4K | 514,023 | D | ↗ |
| 2025-03-27 | PICKERING GRANT | Director / Officer | A-Award | A | Common Stock | 57,938 | 0.00 | — | 508,239 | D | ↗ |
| 2025-03-05 | Eydelman Mikhail | Officer | M-Exempt | D | Stock Option (right to buy) | 5,000 | 21.41 | 107.1K | 144,497 | D | ↗ |
| 2025-03-03 | Wassil Jim | Officer | F-InKind | D | Common Stock | 3,015 | 72.10 | 217.4K | 151,916 | D | ↗ |
| 2025-03-03 | PICKERING GRANT | Director / Officer | F-InKind | D | Common Stock | 7,984 | 72.10 | 575.6K | 498,242 | D | ↗ |
| 2025-03-03 | GUGGENHIME ANDREW | Officer | F-InKind | D | Common Stock | 3,809 | 72.10 | 274.6K | 127,173 | D | ↗ |
| 2025-03-03 | Eydelman Mikhail | Officer | F-InKind | D | Common Stock | 616 | 72.10 | 44.4K | 41,620 | D | ↗ |
| 2025-03-03 | Cowan Elvia | Officer | F-InKind | D | Common Stock | 325 | 72.10 | 23.4K | 24,106 | D | ↗ |
| 2025-02-28 | Wassil Jim | Officer | A-Award | A | Common Stock | 5,649 | 73.02 | 412.5K | 159,070 | D | ↗ |
| 2025-02-28 | PICKERING GRANT | Director / Officer | F-InKind | D | Common Stock | 2,013 | 73.02 | 147.0K | 506,226 | D | ↗ |
| 2025-02-28 | GUGGENHIME ANDREW | Officer | F-InKind | D | Common Stock | 1,270 | 73.02 | 92.7K | 130,982 | D | ↗ |
| 2025-02-28 | Eydelman Mikhail | Officer | F-InKind | D | Common Stock | 470 | 73.02 | 34.3K | 42,236 | D | ↗ |
| 2025-02-28 | Cowan Elvia | Officer | F-InKind | D | Common Stock | 242 | 73.02 | 17.7K | 24,431 | D | ↗ |
| 2025-02-27 | Wassil Jim | Officer | A-Award | A | Stock Option (right to buy) | 72,536 | 74.22 | 5.38M | 72,536 | D | ↗ |
| 2025-02-27 | PICKERING GRANT | Director / Officer | A-Award | A | Stock Option (right to buy) | 193,431 | 74.22 | 14.36M | 193,431 | D | ↗ |
| 2025-02-27 | GUGGENHIME ANDREW | Officer | A-Award | A | Common Stock | 22,761 | 0.00 | — | 132,252 | D | ↗ |
| 2025-02-27 | Eydelman Mikhail | Officer | A-Award | A | Common Stock | 14,484 | 0.00 | — | 42,706 | D | ↗ |
| 2025-02-27 | Cowan Elvia | Officer | A-Award | A | Stock Option (right to buy) | 17,961 | 74.22 | 1.33M | 17,961 | D | ↗ |
| 2025-02-18 | GUGGENHIME ANDREW | Officer | M-Exempt | D | Stock Option (right to buy) | 8,000 | 5.35 | 42.8K | 246,827 | D | ↗ |
| 2025-02-05 | Eydelman Mikhail | Officer | S-Sale | D | Common Stock | 255 | 91.71 | 23.4K | 28,222 | D | ↗ |
| 2025-02-03 | Wassil Jim | Officer | S-Sale | D | Common Stock | 5,314 | 86.00 | 457.0K | 208,381 | D | ↗ |
| 2025-01-21 | GUGGENHIME ANDREW | Officer | M-Exempt | D | Stock Option (right to buy) | 8,000 | 5.35 | 42.8K | 254,827 | D | ↗ |
| 2025-01-15 | Loxam Teri | Director | M-Exempt | D | Stock Option (right to buy) | 6,250 | 22.70 | 141.9K | 6,250 | D | ↗ |
| 2025-01-06 | Eydelman Mikhail | Officer | M-Exempt | D | Stock Option (right to buy) | 5,000 | 21.41 | 107.1K | 154,497 | D | ↗ |
| 2025-01-02 | Wassil Jim | Officer | S-Sale | D | Common Stock | 5,483 | 83.69 | 458.9K | 206,856 | D | ↗ |
| 2024-12-31 | Wassil Jim | Officer | G-Gift | D | Common Stock | 74,000 | 0.00 | — | 131,695 | D | ↗ |
| 2024-12-18 | GUGGENHIME ANDREW | Officer | M-Exempt | D | Stock Option (right to buy) | 8,000 | 5.35 | 42.8K | 262,827 | D | ↗ |
| 2024-12-16 | Cowan Elvia | Officer | M-Exempt | A | Common Stock | 7,716 | 25.92 | 200.0K | 19,294 | D | ↗ |
| 2024-12-09 | Paya Carlos V | Director | G-Gift | D | Stock Option (right to buy) | 7,250 | 72.51 | 525.7K | 0 | D | ↗ |
| 2024-12-09 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 961 | 92.06 | 88.5K | 136,437 | I | ↗ |
| 2024-12-09 | Eydelman Mikhail | Officer | F-InKind | D | Common Stock | 475 | 92.06 | 43.7K | 28,222 | D | ↗ |
| 2024-12-06 | Paya Carlos V | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 5,625 | I | ↗ |
| 2024-12-05 | Eydelman Mikhail | Officer | M-Exempt | D | Stock Option (right to buy) | 5,000 | 21.41 | 107.1K | 159,497 | D | ↗ |
| 2024-12-02 | Wassil Jim | Officer | S-Sale | D | Common Stock | 1,127 | 94.06 | 106.0K | 205,695 | D | ↗ |
| 2024-12-02 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 1,409 | 93.06 | 131.1K | 452,543 | D | ↗ |
| 2024-11-18 | PICKERING GRANT | Director / Officer | G-Gift | D | Common Stock | 710 | 0.00 | — | 465,301 | D | ↗ |
| 2024-11-18 | GUGGENHIME ANDREW | Officer | M-Exempt | D | Stock Option (right to buy) | 8,000 | 5.35 | 42.8K | 270,827 | D | ↗ |
| 2024-11-07 | Wassil Jim | Officer | A-Award | A | Performance Restricted Stock Units | 35,661 | 0.00 | — | 35,661 | D | ↗ |
| 2024-11-07 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 377 | 104.71 | 39.5K | 137,514 | I | ↗ |
| 2024-11-07 | GUGGENHIME ANDREW | Officer | A-Award | A | Performance Restricted Stock Units | 35,661 | 0.00 | — | 35,661 | D | ↗ |
| 2024-11-07 | Eydelman Mikhail | Officer | A-Award | A | Performance Stock Option (right to buy) | 26,125 | 102.70 | 2.68M | 26,125 | D | ↗ |
| 2024-11-07 | Cowan Elvia | Officer | A-Award | A | Performance Stock Option (right to buy) | 11,900 | 102.70 | 1.22M | 11,900 | D | ↗ |
| 2024-11-05 | Eydelman Mikhail | Officer | S-Sale | D | Common Stock | 1,415 | 105.72 | 149.6K | 31,420 | D | ↗ |
| 2024-11-01 | Wassil Jim | Officer | S-Sale | D | Common Stock | 4,955 | 106.34 | 526.9K | 208,740 | D | ↗ |
| 2024-11-01 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 3,312 | 107.34 | 355.5K | 436,952 | D | ↗ |
| 2024-10-28 | Wassil Jim | Officer | M-Exempt | A | Common Stock | 3,464 | 20.93 | 72.5K | 205,695 | D | ↗ |
| 2024-10-25 | GUGGENHIME ANDREW | Officer | M-Exempt | D | Stock Option (right to buy) | 19,108 | 20.93 | 399.9K | 125,892 | D | ↗ |
| 2024-10-18 | GUGGENHIME ANDREW | Officer | M-Exempt | A | Common Stock | 12,000 | 5.35 | 64.2K | 118,383 | D | ↗ |
| 2024-10-07 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 537 | 110.20 | 59.2K | 138,581 | I | ↗ |
| 2024-10-07 | Eydelman Mikhail | Officer | S-Sale | D | Common Stock | 67 | 111.68 | 7.5K | 28,623 | D | ↗ |
| 2024-10-01 | Wassil Jim | Officer | M-Exempt | D | Stock Option (right to buy) | 8,000 | 2.42 | 19.4K | 34,638 | D | ↗ |
| 2024-10-01 | PICKERING GRANT | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 20,000 | 5.35 | 107.0K | 238,717 | D | ↗ |
| 2024-10-01 | Eydelman Mikhail | Officer | S-Sale | D | Common Stock | 1,414 | 113.38 | 160.3K | 32,709 | D | ↗ |
| 2024-09-18 | GUGGENHIME ANDREW | Officer | M-Exempt | D | Stock Option (right to buy) | 8,000 | 5.35 | 42.8K | 320,827 | — | ↗ |
| 2024-09-17 | Loxam Teri | Director | M-Exempt | D | Stock Option (right to buy) | 6,250 | 22.70 | 141.9K | 12,500 | — | ↗ |
| 2024-09-16 | Wassil Jim | Officer | M-Exempt | A | Common Stock | 10,000 | 2.42 | 24.2K | 211,958 | — | ↗ |
| 2024-09-03 | Wassil Jim | Officer | M-Exempt | D | Stock Option (right to buy) | 10,000 | 2.42 | 24.2K | 52,638 | — | ↗ |
| 2024-09-03 | PICKERING GRANT | Director / Officer | F-InKind | D | Common Stock | 13,669 | 110.15 | 1.51M | 465,219 | — | ↗ |
| 2024-09-03 | GUGGENHIME ANDREW | Officer | F-InKind | D | Common Stock | 6,337 | 110.15 | 698.0K | 90,383 | — | ↗ |
| 2024-09-03 | Eydelman Mikhail | Officer | S-Sale | D | Common Stock | 523 | 110.45 | 57.8K | 31,966 | — | ↗ |
| 2024-09-03 | Cowan Elvia | Officer | S-Sale | D | Common Stock | 5,000 | 107.67 | 538.4K | 12,723 | — | ↗ |
| 2024-08-23 | PICKERING GRANT | Director / Officer | M-Exempt | A | Common Stock | 15,000 | 2.03 | 30.5K | 493,888 | — | ↗ |
| 2024-08-19 | GUGGENHIME ANDREW | Officer | S-Sale | D | Common Stock | 4,994 | 78.25 | 390.8K | 99,726 | — | ↗ |
| 2024-08-01 | Wassil Jim | Officer | S-Sale | D | Common Stock | 2,977 | 78.84 | 234.7K | 207,526 | — | ↗ |
| 2024-08-01 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 1,308 | 78.80 | 103.1K | 142,130 | — | ↗ |
| 2024-08-01 | Eydelman Mikhail | Officer | M-Exempt | D | Stock Option (right to buy) | 1,667 | 21.41 | 35.7K | 181,664 | — | ↗ |
| 2024-07-23 | PICKERING GRANT | Director / Officer | M-Exempt | A | Common Stock | 15,000 | 2.03 | 30.5K | 493,888 | — | ↗ |
| 2024-07-18 | GUGGENHIME ANDREW | Officer | S-Sale | D | Common Stock | 2,500 | 81.06 | 202.6K | 99,125 | — | ↗ |
| 2024-07-16 | Cowan Elvia | Officer | M-Exempt | D | Stock Option (right to buy) | 5,000 | 25.92 | 129.6K | 119,000 | — | ↗ |
| 2024-07-08 | Cowan Elvia | Officer | M-Exempt | D | Stock Option (right to buy) | 5,000 | 25.92 | 129.6K | 124,000 | — | ↗ |
| 2024-07-02 | Furey John | Director | A-Award | A | Stock Option (right to buy) | 16,760 | 76.06 | 1.27M | 16,760 | — | ↗ |
| 2024-07-01 | Wassil Jim | Officer | S-Sale | D | Common Stock | 1,663 | 76.71 | 127.6K | 210,614 | — | ↗ |
| 2024-07-01 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 634 | 76.86 | 48.7K | 143,438 | — | ↗ |
| 2024-07-01 | Eydelman Mikhail | Officer | S-Sale | D | Common Stock | 913 | 75.93 | 69.3K | 31,580 | — | ↗ |
| 2024-06-24 | PICKERING GRANT | Director / Officer | M-Exempt | A | Common Stock | 15,000 | 2.03 | 30.5K | 493,888 | — | ↗ |
| 2024-06-18 | GUGGENHIME ANDREW | Officer | S-Sale | D | Common Stock | 7,652 | 71.89 | 550.1K | 97,068 | — | ↗ |
| 2024-06-07 | Eydelman Mikhail | Officer | F-InKind | D | Common Stock | 335 | 70.97 | 23.8K | 30,826 | — | ↗ |
| 2024-06-06 | Paya Carlos V | Director | A-Award | A | Common Stock | 1,550 | 0.00 | — | 4,050 | — | ↗ |
| 2024-06-06 | Lukatch Heath | Director | A-Award | A | Common Stock | 1,550 | 0.00 | — | 7,175 | — | ↗ |
| 2024-06-06 | Loxam Teri | Director | A-Award | A | Common Stock | 1,550 | 0.00 | — | 7,175 | — | ↗ |
| 2024-06-06 | Lee Jacks | Director | A-Award | A | Common Stock | 1,550 | 0.00 | — | 1,550 | — | ↗ |
| 2024-06-06 | Hirth Peter | Director | A-Award | A | Common Stock | 1,550 | 0.00 | — | 7,175 | — | ↗ |
| 2024-06-06 | Gilbert Halley E | Director | A-Award | A | Stock Option (right to buy) | 7,250 | 72.51 | 525.7K | 7,250 | — | ↗ |
| 2024-06-06 | Drapeau Anne S | Director | A-Award | A | Common Stock | 1,550 | 0.00 | — | 7,175 | — | ↗ |
| 2024-06-03 | Wassil Jim | Officer | S-Sale | D | Common Stock | 1,634 | 71.38 | 116.6K | 214,869 | — | ↗ |
| 2024-06-03 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 224 | 73.43 | 16.4K | 144,746 | — | ↗ |
| 2024-06-03 | Gilbert Halley E | Director | S-Sale | D | Common Stock | 18,200 | 73.00 | 1.33M | 5,625 | — | ↗ |
| 2024-06-03 | Eydelman Mikhail | Officer | S-Sale | D | Common Stock | 260 | 73.64 | 19.1K | 31,161 | — | ↗ |
| 2024-05-23 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 8,789 | 69.84 | 613.8K | 477,847 | — | ↗ |
| 2024-05-20 | GUGGENHIME ANDREW | Officer | M-Exempt | D | Stock Option (right to buy) | 8,000 | 5.35 | 42.8K | 352,827 | — | ↗ |
| 2024-05-01 | Wassil Jim | Officer | S-Sale | D | Common Stock | 1,062 | 61.99 | 65.8K | 215,647 | — | ↗ |
| 2024-05-01 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 508 | 62.01 | 31.5K | 146,126 | — | ↗ |
| 2024-05-01 | Eydelman Mikhail | Officer | S-Sale | D | Common Stock | 559 | 61.95 | 34.6K | 30,741 | — | ↗ |
| 2024-04-23 | PICKERING GRANT | Director / Officer | M-Exempt | A | Common Stock | 15,000 | 1.79 | 26.9K | 492,847 | — | ↗ |
| 2024-04-18 | GUGGENHIME ANDREW | Officer | S-Sale | D | Common Stock | 7,624 | 61.24 | 466.9K | 96,055 | — | ↗ |
| 2024-04-17 | Wassil Jim | Officer | M-Exempt | A | Common Stock | 3,551 | 5.35 | 19.0K | 221,840 | — | ↗ |
| 2024-04-01 | Wassil Jim | Officer | S-Sale | D | Common Stock | 677 | 67.23 | 45.5K | 218,289 | — | ↗ |
| 2024-04-01 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 324 | 67.27 | 21.8K | 147,362 | — | ↗ |
| 2024-04-01 | Eydelman Mikhail | Officer | S-Sale | D | Common Stock | 270 | 67.42 | 18.2K | 30,597 | — | ↗ |
| 2024-03-25 | PICKERING GRANT | Director / Officer | M-Exempt | A | Common Stock | 15,000 | 1.79 | 26.9K | 492,847 | — | ↗ |
| 2024-03-18 | GUGGENHIME ANDREW | Officer | M-Exempt | D | Stock Option (right to buy) | 8,000 | 5.35 | 42.8K | 368,827 | — | ↗ |
| 2024-03-15 | Wassil Jim | Officer | A-Award | A | Common Stock | 4,099 | 0.00 | — | 222,773 | — | ↗ |
| 2024-03-11 | PICKERING GRANT | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 65,000 | 2.03 | 132.0K | 227,327 | — | ↗ |
| 2024-03-02 | Wassil Jim | Officer | F-InKind | D | Common Stock | 2,178 | 71.55 | 155.8K | 218,674 | — | ↗ |
| 2024-03-02 | PICKERING GRANT | Director / Officer | F-InKind | D | Common Stock | 7,967 | 71.55 | 570.0K | 412,847 | — | ↗ |
| 2024-03-02 | GUGGENHIME ANDREW | Officer | F-InKind | D | Common Stock | 3,795 | 71.55 | 271.5K | 95,679 | — | ↗ |
| 2024-03-02 | Eydelman Mikhail | Officer | F-InKind | D | Common Stock | 613 | 71.55 | 43.9K | 30,597 | — | ↗ |
| 2024-03-02 | Cowan Elvia | Officer | F-InKind | D | Common Stock | 324 | 71.55 | 23.2K | 12,156 | — | ↗ |
| 2024-03-01 | Wassil Jim | Officer | S-Sale | D | Common Stock | 763 | 74.70 | 57.0K | 220,852 | — | ↗ |
| 2024-03-01 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 363 | 74.69 | 27.1K | 148,670 | — | ↗ |
| 2024-03-01 | Eydelman Mikhail | Officer | M-Exempt | A | Common Stock | 1,667 | 21.41 | 35.7K | 32,877 | — | ↗ |
| 2024-03-01 | Cowan Elvia | Officer | S-Sale | D | Common Stock | 4,901 | 74.90 | 367.1K | 12,480 | — | ↗ |
| 2024-02-29 | Wassil Jim | Officer | A-Award | A | Common Stock | 20,000 | 0.00 | — | 223,852 | — | ↗ |
| 2024-02-29 | PICKERING GRANT | Director / Officer | A-Award | A | Stock Option (right to buy) | 205,000 | 73.82 | 15.13M | 205,000 | — | ↗ |
| 2024-02-29 | GUGGENHIME ANDREW | Officer | A-Award | A | Stock Option (right to buy) | 90,000 | 73.82 | 6.64M | 90,000 | — | ↗ |
| 2024-02-29 | Eydelman Mikhail | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 73.82 | 3.69M | 50,000 | — | ↗ |
| 2024-02-29 | Cowan Elvia | Officer | A-Award | A | Stock Option (right to buy) | 25,000 | 73.82 | 1.85M | 25,000 | — | ↗ |
| 2024-02-26 | PICKERING GRANT | Director / Officer | M-Exempt | A | Common Stock | 30,000 | 1.79 | 53.7K | 405,814 | — | ↗ |
| 2024-02-23 | PICKERING GRANT | Director / Officer | M-Exempt | A | Common Stock | 15,000 | 1.79 | 26.9K | 390,814 | — | ↗ |
| 2024-02-20 | GUGGENHIME ANDREW | Officer | S-Sale | D | Common Stock | 340 | 75.80 | 25.8K | 79,474 | — | ↗ |
| 2024-02-15 | Wassil Jim | Officer | M-Exempt | A | Common Stock | 27,917 | 2.42 | 67.6K | 203,852 | — | ↗ |
| 2024-02-01 | Wassil Jim | Officer | S-Sale | D | Common Stock | 467 | 74.14 | 34.6K | 176,885 | — | ↗ |
| 2024-02-01 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 255 | 75.47 | 19.2K | 149,978 | — | ↗ |
| 2024-02-01 | Eydelman Mikhail | Officer | S-Sale | D | Common Stock | 474 | 75.39 | 35.7K | 20,710 | — | ↗ |
| 2024-01-31 | Lukatch Heath | Director | M-Exempt | D | Stock Option (right to buy) | 5,000 | 16.00 | 80.0K | 6,000 | — | ↗ |
| 2024-01-29 | PICKERING GRANT | Director / Officer | M-Exempt | A | Common Stock | 30,000 | 1.79 | 53.7K | 405,814 | — | ↗ |
| 2024-01-29 | Lukatch Heath | Director | M-Exempt | D | Stock Option (right to buy) | 4,000 | 16.00 | 64.0K | 11,000 | — | ↗ |
| 2024-01-23 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 10,023 | 63.95 | 641.0K | 377,853 | — | ↗ |
| 2024-01-18 | GUGGENHIME ANDREW | Officer | M-Exempt | D | Stock Option (right to buy) | 8,000 | 5.35 | 42.8K | 384,827 | — | ↗ |
| 2024-01-02 | Wassil Jim | Officer | S-Sale | D | Common Stock | 1,039 | 63.55 | 66.0K | 177,607 | — | ↗ |
| 2024-01-02 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 97 | 62.91 | 6.1K | 152,497 | — | ↗ |
| 2024-01-02 | Lukatch Heath | Director | S-Sale | D | Common Stock | 4,164 | 64.28 | 267.7K | 5,916 | — | ↗ |
| 2024-01-02 | Eydelman Mikhail | Officer | S-Sale | D | Common Stock | 928 | 64.31 | 59.7K | 20,710 | — | ↗ |
| 2023-12-26 | PICKERING GRANT | Director / Officer | M-Exempt | A | Common Stock | 10,000 | 0.04 | 400.00 | 390,814 | — | ↗ |
| 2023-12-22 | PICKERING GRANT | Director / Officer | M-Exempt | A | Common Stock | 9,900 | 2.03 | 20.1K | 380,814 | — | ↗ |
| 2023-12-18 | GUGGENHIME ANDREW | Officer | M-Exempt | A | Common Stock | 8,000 | 5.35 | 42.8K | 87,474 | — | ↗ |
| 2023-12-14 | GUGGENHIME ANDREW | Officer | M-Exempt | D | Stock Option (right to buy) | 14,000 | 5.35 | 74.9K | 400,827 | — | ↗ |
| 2023-12-07 | Eydelman Mikhail | Officer | M-Exempt | A | Stock Option (right to buy) | 10,000 | 21.41 | 214.1K | 195,000 | — | ↗ |
| 2023-12-01 | Wassil Jim | Officer | M-Exempt | D | Stock Option (right to buy) | 3,000 | 2.42 | 7.3K | 96,555 | — | ↗ |
| 2023-12-01 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 468 | 51.43 | 24.1K | 153,435 | — | ↗ |
| 2023-11-27 | Lee Jacks | Director | A-Award | A | Stock Option (Right to Buy) | 30,000 | 50.13 | 1.50M | 30,000 | — | ↗ |
| 2023-11-24 | PICKERING GRANT | Director / Officer | S-Sale | D | Common Stock | 3,779 | 49.46 | 186.9K | 370,914 | — | ↗ |
| 2023-11-20 | GUGGENHIME ANDREW | Officer | M-Exempt | A | Common Stock | 8,000 | 5.35 | 42.8K | 87,474 | — | ↗ |
| 2023-11-09 | Paya Carlos V | Director | G-Gift | A | Stock Option (right to buy) | 30,000 | 22.02 | 660.6K | 30,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
144.39M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Grant E. Pickering | Co-Founder, Chief Executive Officer & Director | 1M | male |
| Andrew L. Guggenhime | President & Chief Financial Officer | 960.2K | male |
| Mikhail Eydelman | Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary | 752.7K | male |
| Harp Dhaliwal | Chief Technical Operations Officer | 743.6K | male |
| James Wassil | Executive Vice President & Chief Operating Officer | 614.7K | male |
| Jeff Macdonald | Executive Director of Investor Relations | — | male |
| Mike Mullette | Chief Commercial Officer | — | male |
| Sam Iki | Senior Vice President of Project Management | — | — |
| Whitney Jones | Chief People Officer | — | female |
| Chris Griffith | Chief Business & Strategy Officer | — | male |
| Elvia Cowan | Senior VP of Finance & Chief Accounting Officer | — | female |
| Janet Graesser | Senior Vice President of Corporate Affairs | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PCVX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
